Last reviewed · How we verify
NCT05957562: EArAzygousvp
Azygos Vein Preservation; Its Impact on Early Outcomes After Neonatal EA/TOF Repair
NA trial testing EA/TOF primary repair with Azygos vein preservation in Azygos Vein Preservation Versus Disconnection in 64 participants. Completed in 9 April 2023.
6 October 2022
Quick facts
| Lead sponsor | dr. Muhammad Abdelhafez Mahmoud, MD |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 10 April 2020 |
| Primary completion | 6 October 2022 |
| Estimated completion | 9 April 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- EA/TOF primary repair with Azygos vein preservation
- EA/TOF primary repair with Azygos vein sacrifice (disconnection)
Conditions studied
- Azygos Vein Preservation Versus Disconnection — all drugs for Azygos Vein Preservation Versus Disconnection →
- Tracheo-Esophageal Fistula With Atresia of Esophagus — all drugs for Tracheo-Esophageal Fistula With Atresia of Esophagus →
- Leak, Anastomotic — all drugs for Leak, Anastomotic →
- Stricture Esophagus — all drugs for Stricture Esophagus →
Sponsor
dr. Muhammad Abdelhafez Mahmoud, MD
Who can join
Adults 1 Day to 28 Days, any sex, with Azygos Vein Preservation Versus Disconnection or Tracheo-Esophageal Fistula With Atresia of Esophagus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Azygos vein preservation revisited: impact on early outcomes after repair of Esophageal atresia/ Tracheo-Esophageal Fistula in newborns. A randomized controlled study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Azygos vein preservation revisited: impact on early outcomes after repair of esophageal atresia/tracheoesophageal fistula in newborns.
Daboos M, Abdelmaboud M, Hussein M, Salama A, et al · · 2023 · cited 2× · PMID 37945968 · DOI 10.1007/s13304-023-01684-4
Verify or expand the search:
- PubMed search for NCT05957562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other dr. Muhammad Abdelhafez Mahmoud, MD trials
Trials by the same sponsor.
- NCT06113978 — Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Patients Below 18 · NA · completed
- NCT04990570 — Telemedicine (Virtual Clinic) for Pediatric Surgery During Covid-19 Pandemic · completed
- NCT05144659 — Evaluation of Double Faced Transverse Preputial Onlay Island Flap for Hypospadias Repair in Pediatrics · NA · completed
- NCT04821167 — Safety and Efficiency of Laparoscopic Management of Intra-canalicular (Emergent) Testis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05957562 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by dr. Muhammad Abdelhafez Mahmoud, MD
- Last refreshed: 24 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05957562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing